13/05/2025 – Regulatory challenges and biocompatibility tests
Medical textiles in the global market
Technological advances and increasing demand for specialised textile applications are driving the growth of the medical textile industry and manufacturers must navigate the complex landscape of global regulations to ensure safety and efficacy.
A proactive approach to biocompatibility and microbial testing can support product development and innovation and improve product safety and efficacy. © Hohenstein
A proactive approach to biocompatibility and microbial testing can support product development and innovation and improve product safety and efficacy. © Hohenstein
Dr Timo Hammer is CEO of Hohenstein Laboratories, a testing and research service provider for softlines, hardlines and medical products. Headquartered in Bönnigheim, the family-owned company operates globally and employs around 1,200 people. Mr Hammer holds a doctorate from the University of Stuttgart-Hohenheim and is an expert in the development and testing of medical devices. © Hohenstein